BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Ocular Therapeutix™ To Report Second Quarter 2019 Financial Results

  Following distribution of the earnings release via wire services, the Ocular Therapeutix management team will host a live conference call and webcast at 4:30 p.m. Eastern Time to review the Company’s financial results and provide a general business update.

  August 1, 2019

   · 

  2 min read
• Biotech Bay

  Blade Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference

  Wendye Robbins, M.D., President and Chief Executive Officer, will present at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at 2:30 p.m. Eastern Time.

  August 1, 2019

   · 

  1 min read
• Business

  Savara to Report Second Quarter 2019 Financial Results and Provide Business Update

  Shareholders and other interested parties may access the conference call by dialing (855) 239-3120 from the U.S., (855) 669-9657 from Canada, and (412) 542-4127 from elsewhere outside the U.S. and request the “Savara Inc.” call.

  August 1, 2019

   · 

  2 min read
• Business

  Horizon Therapeutics plc Appoints Dr. Sue Mahony to Board of Directors

  Dr. Mahony brings more than three decades of broad cross-functional and global experience to the board.

  August 1, 2019

   · 

  2 min read
• Business

  Clovis Oncology Announces Second Quarter 2019 Operating Results

  $33.0M in Rubraca® (rucaparib) net product revenue for Q2 2019 compared to $23.8M for Q2 2018

  August 1, 2019

   · 

  21 min read
• Biotech Beach

  Nihon Kohden Achieves Great Place to Work® Status for Fourth Consecutive Year

  Employee Satisfaction Contributes to Nihon Kohden’s Success as Fastest-Growing Company in Patient Monitoring Segment

  August 1, 2019

   · 

  3 min read
• Genetown

  Stoke Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

  Chief Executive Officer Edward M. Kaye, M.D., will participate in a fireside chat at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at 9:00 a.m. ET in Boston, Mass.

  August 1, 2019

   · 

  1 min read
• Business

  I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors

  I-Mab entered into a research collaboration with Roche in April 2019 where Roche agreed to supply TECENTRIQ® to I-Mab for use in clinical study in combination with TJD5.

  August 1, 2019

   · 

  6 min read
• Business

  Javara and Tryon Medical Partners Working Together to Build a Robust Clinical Trials Offering

  Javara and Tryon Medical Partners announced that they have formed a collaboration to offer industry-sponsored, outpatient clinical trials to Tryon Medical Partners’ patients.

  August 1, 2019

   · 

  2 min read
• Business

  Access Scientific, LLC unveils partnership with Smiths Medical to sell Access’ POWERWAND product lines and completion of a $20M capital raise

  Healthcare providers to benefit from significantly improved access to the clinically superior POWERWAND, shown to reduce CLABSIs and the overall cost of care

  August 1, 2019

   · 

  3 min read